본문 바로가기
KERD
논문KCI 등재

성인의 고혈압, 당뇨병, 이상지질혈증으로 인한 총 진료비 중 과체중 및 비만의 기여분 : 국민건강영양조사자료와 국민건강보험공단 자료를 중심으로

Medical Expenditure Attributable to Overweight and Obesity in Adults with Hypertension, Diabetes and Dyslipidemia : Evidence from Korea National Health and Nutrition Examination Survey Data and Korea National Health Corporation Data

0

조회

0

다운로드

13

인용

0

참고문헌

키워드

초록

이 연구는 고혈압, 당뇨병, 이상지질혈증으로지출된 진료비 중 과체중 및 비만의 기여분을 추계하기 위한 질병비용연구로서 국민건강보험공단의 건강검진 및 건강보험급여 자료를 활용한 연구이다. 연구결과 2005년 현재 고혈압, 당뇨병,이상지질혈증 때문에 지출된 총 진료비 중 과체중 및 비만의 기여분은 각각 4,561억원(4,328억원-4,805억원), 2,823억원(2,487억원-3,176억원), 165억원(147억원-183억원)이었고, 이를 모두 합하면7,549억원(6,961억원-8,164억원)이었다. 이는 해당연도의 고혈압 총 진료비의 34.6%(32.9%-36.5%),당뇨병 총 진료비의 32.5%(28.6%-36.6%), 이상지질혈증 총 진료비의 19.4%(17.3%-21.6%)를 차지한다. 또한 이 세 가지 질병의 총 진료비를 기준으로 했을 때 과체중 및 비만이 기여한 금액은33.3%(30.7%-36.0%)에 해당하였다. 이는 과체중과 비만을 예방한다면 고혈압, 당뇨병, 이상지질혈증으로 지출되는 총 진료비의 33.3%를 감소시킬 수 있다는 의미이며, 향후 만성질환 예방과관련하여 과체중 및 비만의 예방관리사업이 얼마나중요한가를 시사해 주는 것이다.

Abstract

Objectives: This study was conducted to estimate medical expenditure attributable to overweight and obesity in adults with hypertension, diabetes and dyslipidemia using Korea National Health and Nutrition Examination survey data and Korea National Health Corporation data. Methods: The medical expenditure of hypertension, diabetes and dyslipidemia related to overweight and obesity were composed of inpatient care costs, outpatient care costs and medication costs. The population attributable risk (PAR) of overweight and obesity was calculated from national representative data of Korea such as the National Health Insurance Corporation cohort data and 2005 Korea National Health and Nutrition Examination survey data. Results: The medical expenditure attributable to overweight and obesity of hypertension were 456 billion won (men : 215 billion won, women : 241 billion won). Those of diabetes were 282 billion won (men : 148 billion won, women : 135 billion won), and of dyslipidemia were 17 billion won (men : 9 billion won, women : 8 billion won). Consequently, these costs corresponded to 33.3% of total medical expenditure due to hypertension,diabetes and dyslipidemia. Conclusions: We found a substantial medical expenditure due to overweight and obesity of hypertension,diabetes and dyslipidemia were very high. In order to reduce these costs, effective national strategies for prevention and management of overweight and obesity should be established and implemented.

참고문헌 (30)

  1. Bonow RO, "World Heart Day 2002: the international burden of cardiovascular disease: responding to the emerging global epidemic", Circulation, 106, pp.1602~1605 (2002)
  2. WHO, "Obesity-preventing and managing the global epidemic", World Health Organization: Geneva, ~ (1997)
  3. Park SH, "Waist circumference and waist-to-height ratio as predictors of cardiovascular disease risk in Korean adults", Circ J, 73, pp.1643~1650 (2009)
  4. Hedley AA, "Prevalence of overweight and obesity among US children, adolscent, and adults, 1999-2002", JAMA, 291, pp.2847~2850 (2004)
  5. Hubert HB, "Obesity as an independent risk factor for cardiovascular disease: A 26-year follow-up of participants in the Framingham Heart Study", Circulation, 67, pp.968~977 (1983)
  6. Alberti KG, "Metabolic syndrome: A new world-wide definition: A Consensus Statement from the International Diabetes Federation", Diabe Med, 23, pp.469~480 (2006)
  7. Friedewald WT, "Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge", Clin Chem, 18, pp.499~502 (1972)
  8. Hsieh SD, "Waist", height ratio as a simple and useful predictor of coronary heart disease risk factors in women, 1995, pp.34, 1147~1152
  9. Hsieh SD, "Abdominal fat distribution and coronary heart disease risk factors in men-waist", height ratio as a simple and useful predictor, 1995, pp.19, 585~589
  10. United States. Dept. of Health and Human Services, "Healthy people 2010: understanding and improving health" (2001), Jones and Bartlett Publishers
  11. 서미경, "새국민건강증진계획수립", pp.305~323 (2006), 보건복지부, 한국보건사회연구원
  12. 보건복지가족부 질병정책과, "2009년도 주요 만성질환관리사업 안내", 보건복지가족부 질병정책과, ~ (2009)
  13. Swinburn B, "Health care costs of obesity in New Zealand", Int J Obes Relat Metab Disord, 21(10), pp.891~896 (1997)
  14. Birmingham CL, "The cost of obesity in Canada", CMAJ, 160, pp.483~488 (1999)
  15. Zhao W, "Economic burden of obesity-related chronic diseases in Mainland China", Obes Rev., 9(Suppl 1), pp.62~67 (2008)
  16. 정백근, "한국인 성인 비만의 사회경제적 비용", 예방의학회지, 35(1), pp.1~12 (2002), 대한예방의학회
  17. 김정희, "2005년도 건강보험환자의 본인부담 진료비 실태조사" (2006), 국민건강보험공단
  18. Khan LK, "Recommended community strategies and measurements to prevent obesity in the United States", MMWR Recomm Rep, 58(RR-7), pp.1~26 (2009)
  19. Kantachuvessiri A, "Obesity in Thailand", J Med Assoc Thai, 88(4), pp.554~562 (2005)
  20. Ismail MN, "Obesity in Malaysia", Obes Rev, 3(3), pp.203~208 (2002)
  21. Ginter E, "Adult obesity at the beginning of the 21st century: epidemiology, pathophysiology and health risk", Bratisl Lek Listy, 109(5), pp.224~230 (2008)
  22. Kim NS, "Increasing prevalence of obesity related disease for Koreans associated with overweight and obesity", Korean J Prev Med, 34(4), pp.309~315 (2001)
  23. Bjornelv S, "Sex differences in time trends for overweight and obesity in adolescents: The Young-HUNT study", Scand J Public Health, 37(8), pp.881~889 (2009)
  24. Fu T, "Costs of metabolic syndrome - related diseases induced by obesity in Taiwan", Obes Rev, 9(suppl 1), pp.68~73 (2008)
  25. Drummond MF, "Principles of economic appraisal in health care", Oxford University, 10~12 (1980)
  26. Jarl J, "The societal cost of alcohol consumption: an estimation of the economic and human cost including health effects in Sweden, 2002", Eur J Health Econ, 9(4), pp.351~360 (2008)
  27. Casado V, "An approach to estimating the intangible costs of multiple sclerosis according to disability in Catalonia, Spain", Multiple Sclerosis, 13, pp.800~804 (2007)
  28. Finkelstein EA, "National medical spending attributable to overweight and obesity: how much, and who's paying?", Health Aff 2003, ~ (2003)
  29. Thompson D, "The medical-care cost burden of obesity", Obes Rev, 2, pp.189~197 (2001)
  30. Sturm R, "The effects of obesity, smoking, and drinking on medical problems and costs", Health Aff(Millwood), 21(2), pp.245~253 (2002)

관련 논문AI추천

이 간행물의 다른 논문 (8건)